<DOC>
	<DOCNO>NCT01710267</DOCNO>
	<brief_summary>Rivaroxaban ( RXA ; brand name Xarelto® ) oral direct factor Xa inhibitor apply prophylaxis venous thromboembolism major orthopedic surgery . Additionally , RXA approve Swissmedic use therapeutic dose primary therapy VTE prophylaxis cerebrovascular event non-valvular atrial fibrillation . This explorative laboratory study evaluate intra-individual variability RXA conc . time standardize assay among 9 Swiss laboratory determine RXA conc .</brief_summary>
	<brief_title>Rivaroxaban Laboratory Monitoring Switzerland 2 : Therapeutic Dose ( RivaMoS 2 )</brief_title>
	<detailed_description>Rivaroxaban ( RXA ; brand name Xarelto® ) oral direct factor Xa inhibitor apply prophylaxis venous thromboembolism ( VTE ) major orthopedic surgery lower limbs hip knee replacement surgery . Additionally , RXA approve Swissmedic use therapeutic dose primary therapy VTE prophylaxis cerebrovascular event non-valvular atrial fibrillation . Monitoring RXA concentration ( conc . ) generally require stable pharmacokinetic pharmacodynamic profile , even patient renal insufficiency . However , several clinical situation , may desirable measure RXA plasma conc . The range RXA conc . wide among individual typical peak level median 244 µg/L ( IQR 175-360 ) trough level median 32 µg/L ( IQR 19-60 ) daily dose 20 mg RXA . This explorative laboratory study evaluate intra-individual variability RXA conc . time standardize assay among 9 Swiss laboratory determine RXA conc .</detailed_description>
	<mesh_term>Rivaroxaban</mesh_term>
	<criteria>Male , age 1865 year No know comorbidity disease No know galactose intolerance , lactase deficiency glucose galactose malabsorption Taking medicament No history disorder regard hemostasis Initial screen laboratory test show normal value liver/pancreas function ( ALAT , ASAT , gGT , alkalic phosphatase , bilirubin , amylase , lipase ) , kidney function ( creatinine ) , hematogram ( white blood cell count , hemoglobin , platelet count ) , coagulation parameter ( `` Gerinnungsstatus '' PT , aPTT , fibrinogen , thrombin time ) write informed consent</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2015</verification_date>
</DOC>